Αποτελέσματα Αναζήτησης
12 Σεπ 2023 · We used conventional search methods to identify 1459 publications from 2021 to 2022 using ADNI data/samples and reviewed 291 impactful studies. This review details how ADNI studies improved disease progression understanding and clinical trial efficiency.
22 Ιαν 2021 · Our major contributions are the application of (i) measures from the rich ADNI dataset, (ii) features defining trajectories of change in relevant cognitive and MRI measures, and (iii) a data ...
11 Σεπ 2024 · This article provides an overview of the ADNI MRI core for the special issue of the journal highlighting 20 years of the ADNI study. We do not review the results of publications using ADNI MRI data in this article because a comprehensive review of studies using ADNI data, including MRI, was recently published. 6.
The Alzheimer's Disease Neuroimaging Initiative (ADNI) is an ongoing, longitudinal, multicenter study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimer's disease (AD).
1 Μαΐ 2010 · The Alzheimer's Disease Neuroimaging Initiative (ADNI) beginning in October 2004, is a 6-year research project that studies changes of cognition, function, brain structure and function, and biomarkers in elderly controls, subjects with mild cognitive impairment, and subjects with Alzheimer's disease (AD).
This paper reviews the current status of the Clinical Core of the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and summarizes planning for the next stage of the project.
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a longitudinal, multi-center, observational study. The overall goal of ADNI is to validate biomarkers for Alzheimer’s disease (AD) clinical trials.
